| Dr Madeline Harrison, AUD | |
|
10238 E Hampton Ave Ste 402, Mesa, AZ 85209-3319 | |
| (602) 956-1250 | |
| Not Available |
| Full Name | Dr Madeline Harrison |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 3 Years |
| Location | 10238 E Hampton Ave Ste 402, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881338259 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | DA13092 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Biltmore Ear Nose And Throat Pc | 8527042530 | 13 |
News Archive
A large, multicenter study found that the Breast Imaging and Reporting Data Systems (BI-RADS) terminology used by radiologists to classify breast imaging results is useful in predicting malignancy in breast lesions detected with MRI. Results of the study are published online in the journal Radiology.
These findings from the Congressional Budget Office, based on 20 years of efforts to shift the program, are a blow to ongoing Medicare projects as well as a key component of the health law.
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response - a discovery that may pave the way for new treatments for many human diseases.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
› Verified 9 days ago
| Provider Name | Biltmore Ear Nose And Throat Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942489042 PECOS PAC ID: 8527042530 Enrollment ID: O20040616001470 |
News Archive
A large, multicenter study found that the Breast Imaging and Reporting Data Systems (BI-RADS) terminology used by radiologists to classify breast imaging results is useful in predicting malignancy in breast lesions detected with MRI. Results of the study are published online in the journal Radiology.
These findings from the Congressional Budget Office, based on 20 years of efforts to shift the program, are a blow to ongoing Medicare projects as well as a key component of the health law.
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response - a discovery that may pave the way for new treatments for many human diseases.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Madeline Harrison, AUD 898 W Juniper Ave, Gilbert, AZ 85233-4236 Ph: (253) 548-7862 | Dr Madeline Harrison, AUD 10238 E Hampton Ave Ste 402, Mesa, AZ 85209-3319 Ph: (602) 956-1250 |
News Archive
A large, multicenter study found that the Breast Imaging and Reporting Data Systems (BI-RADS) terminology used by radiologists to classify breast imaging results is useful in predicting malignancy in breast lesions detected with MRI. Results of the study are published online in the journal Radiology.
These findings from the Congressional Budget Office, based on 20 years of efforts to shift the program, are a blow to ongoing Medicare projects as well as a key component of the health law.
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response - a discovery that may pave the way for new treatments for many human diseases.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
› Verified 9 days ago
Jennifer Sellinger, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1025 N Country Club Dr, Mesa, AZ 85201 Phone: 480-472-0510 | |
Dr. Elizabeth Dawn Palmer, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 4838 E Baseline Rd Ste 126, Mesa, AZ 85206 Phone: 480-265-8067 Fax: 623-806-8685 | |
Olivia H Bender, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1520 S Dobson Rd Ste 217, Mesa, AZ 85202 Phone: 480-539-4000 | |
Tri-city Audiology, Llc Audiologist Medicare: Medicare Enrolled Practice Location: 6553 E Baywood Ave Ste 104, Mesa, AZ 85206 Phone: 480-981-3384 Fax: 480-924-8944 | |
Advanced Hraing Group Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5202 E Main St Ste 105, Mesa, AZ 85205 Phone: 480-218-1328 Fax: 480-218-1330 | |
Edgeline Audiology Pllc Audiologist Medicare: Medicare Enrolled Practice Location: 4140 E Baseline Rd Ste 101, Mesa, AZ 85206 Phone: 480-545-2215 | |
Soha Garadat, M.SC. PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4838 E Baseline Rd Ste 126, Mesa, AZ 85206 Phone: 480-265-8067 |